Abstract
Multiple sclerosis is a chronic inflammatory demyelinating disease which affect central nervous system with neurodegenerative changes of brain. This autoimmune disease manifests itself with various symptoms.
Treatment options in multiple sclerosis have expanded considerably in the recent years. This review explore current treatment options for multiple sclerosis.
We report one casee from our own patients base through we demonstrate possible use of fingolimod for treatment escalation.